Saudi Arabia Biotechnology Reagents & Kits Market By Type (Purification Kits, Amplification Kits, Detection Kits, Isolation Kits, Others), By Technology (LAMP technology, PCR, Cell Culture, Sequencing, Chromatography, Electrophoresis, Flow Cytometry, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Saudi Arabia Biotechnology Reagents & Kits Market was valued at USD 42.76 Million in 2024 and is expected to reach USD 51.60 Million by 2030 with a CAGR of 3.38% during the forecast period. The Saudi Arabia biotechnology reagents and kits market is witnessing significant growth, fueled by increasing demand for advanced diagnostic tools, research applications, and pharmaceutical development. Reagents and kits play a critical role in various biotechnology processes, including molecular biology, cell culture, drug development, and clinical diagnostics, making them essential components for the expanding biotech and pharmaceutical industries in the Kingdom.

The rise in research and development (R&D) activities across academic institutions, government research centers, and private enterprises has significantly contributed to the growing demand for biotechnology reagents and kits. These products are crucial for conducting experiments in genetic engineering, immunology, and proteomics, supporting the country's broader efforts to advance scientific innovation and medical breakthroughs.

As the biotechnology sector in Saudi Arabia continues to expand, the market for reagents and kits is expected to grow in tandem, offering substantial opportunities for both domestic and international companies to tap into the growing demand for high-quality, specialized products.

Key Market Drivers

Growth in Healthcare Industry

The expansion of Saudi Arabia's healthcare industry is emerging as a significant driver of growth in the country's biotechnology reagents and kits market. With the government’s ongoing commitment to modernizing healthcare infrastructure as part of its Vision 2030 initiative, there is a rising demand for advanced medical diagnostics, research tools, and laboratory products, including biotechnology reagents and kits. These essential components play a pivotal role in various healthcare applications, from disease diagnostics to drug development and clinical research.

One of the key factors driving this market is the increasing need for accurate and rapid diagnostic solutions in healthcare facilities. In February 2025, Saudi German Health (SGH) signed a Memorandum of Understanding (MoU) with Becton, Dickinson and Company (BD), a global leader in advanced healthcare solutions, aimed at transforming healthcare services through the introduction of rapid diagnostic solutions. This groundbreaking collaboration marks a first in the region, setting a new benchmark for future healthcare innovations. Focused on cutting-edge laboratory technologies, the partnership will bring advanced devices like Bactec, Phoenix, Epicenter, and MALDI-TOF to the forefront, significantly enhancing diagnostic capabilities and elevating patient care standards.

With the growing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, healthcare providers are turning to biotechnology reagents and kits to enhance the precision and efficiency of diagnostic processes. Young adults in Saudi Arabia face a heightened risk of cardiovascular diseases (CVDs) and have only limited awareness of the associated risk factors. The most prevalent CVD risk factor among this group is excessive weight. Males with elevated cholesterol levels are more prone to developing CVDs compared to females. In females, factors such as waist-to-hip ratio, body mass index (BMI), and blood pressure (BP) show a significant correlation with the onset of CVD events. These products enable laboratories to perform molecular and genetic testing, detect pathogens, and analyze biomarkers, contributing to earlier diagnosis and improved patient outcomes.

Surge in Technological Advancements

Recent breakthroughs in molecular biology, such as CRISPR gene editing, next-generation sequencing (NGS), and polymerase chain reaction (PCR), have increased the demand for specialized biotechnology reagents and kits. In January 2024, Vertex Pharmaceuticals Incorporated announced that the Saudi Food and Drug Authority (SFDA) has granted Marketing Authorization for CASGEVY (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy. This approval is for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in individuals aged 12 and older. These cutting-edge techniques require high-precision reagents and consumables for applications like genetic research, genome mapping, and diagnostic testing, contributing to a surge in the use of advanced biotechnology kits. As research institutions, healthcare providers, and biotechnology firms in Saudi Arabia adopt these techniques, the demand for reagents designed for precision and accuracy has increased, driving market expansion.

The growing focus on personalized medicine and precision therapeutics in Saudi Arabia has led to an increased need for specialized reagents and kits used in diagnostic tests and therapeutic monitoring. Personalized medicine requires precise molecular and genetic data to tailor treatments to individual patients, driving demand for reagents used in DNA analysis, protein detection, and biomarker identification. As healthcare providers in Saudi Arabia shift towards more individualized care, biotechnology reagents that support this precision approach are experiencing a surge in demand.

Download Free Sample Report

Key Market Challenges

Limited Local Manufacturing Capabilities

Limited local manufacturing capabilities pose a significant challenge to the growth of the Saudi Arabia biotechnology reagents and kits market. Currently, much of the country’s supply for these essential products is imported from international manufacturers, creating dependency on external sources to meet domestic demand. This reliance on imports can lead to increased costs, longer lead times, and potential disruptions in the supply chain, especially during periods of global market instability or geopolitical tensions.

The lack of local manufacturing infrastructure not only limits the availability of reagents and kits but also impedes the country’s ability to rapidly respond to the growing demand for specialized biotechnology products. This is particularly concerning as the Kingdom aims to advance its biotechnology and healthcare sectors, including the adoption of cutting-edge diagnostic tools and personalized medicine solutions. Without a robust local manufacturing base, the biotechnology reagents and kits market may struggle to fully support the ambitious research and development (R&D) activities taking place across Saudi Arabia’s academic institutions, pharmaceutical companies, and research centers.

Key Market Trends

Rising Demand for Molecular Diagnostics

The rising demand for molecular diagnostics has emerged as a prominent trend in Saudi Arabia’s biotechnology reagents and kits market. Saudi Diagnostic Limited (SDL) is a leading provider of advanced diagnostic services and solutions in Saudi Arabia. Founded to address the increasing demands of the healthcare sector, SDL leverages state-of-the-art technologies and expertise in diagnostics, molecular diagnostics, and laboratory management. Their dedication to excellence drives their contribution to healthcare advancement, enhancing patient care and improving outcomes across the Kingdom. As healthcare providers increasingly prioritize precision medicine and early disease detection, molecular diagnostics are becoming essential tools for identifying and managing a wide range of medical conditions. This growing demand is driving significant advancements in the biotechnology reagents and kits sector, with manufacturers and suppliers adapting to meet the needs of modern laboratories and healthcare facilities.

One of the key drivers behind this trend is the rising prevalence of chronic and infectious diseases in Saudi Arabia, including diabetes, cardiovascular diseases, cancer, and viral infections such as COVID-19. Molecular diagnostics enable healthcare professionals to detect genetic mutations, pathogens, and other molecular markers with high precision, leading to more accurate diagnoses and personalized treatment plans. The increased use of polymerase chain reaction (PCR) tests, next-generation sequencing (NGS), and other molecular techniques requires a steady supply of high-quality reagents and kits, which are vital for ensuring reliable results.

Segmental Insights

Type Insights

Based on Type, Purification Kits have emerged as the fastest growing segment in the Saudi Arabia Biotechnology Reagents & Kits Market in 2024. The growing emphasis on high-quality research in Saudi Arabia’s biotechnology sector has led to a rising demand for purification kits that ensure the removal of contaminants and impurities from samples. In applications such as genomics, proteomics, and drug discovery, it is critical to obtain pure and reliable samples to produce accurate results. Purification kits provide the precision and consistency required for these processes, making them essential tools in both research and development.

Technology Insights

Based on Technology, LAMP technology have emerged as the fastest growing segment in the Saudi Arabia Biotechnology Reagents & Kits Market during the forecast period. This is due to several compelling factors. One of the key reasons is the increasing demand for rapid, reliable, and cost-effective molecular diagnostics, especially in the wake of the COVID-19 pandemic, which underscored the need for efficient diagnostic tools. LAMP technology allows for the amplification of nucleic acids at a constant temperature, eliminating the need for expensive thermocyclers used in traditional PCR methods. This makes it an attractive option for laboratories and healthcare providers seeking to reduce costs while maintaining high diagnostic accuracy.

Download Free Sample Report

Regional Insights

Based on Region, Northern & Central have emerged as the dominating region in the Saudi Arabia Biotechnology Reagents & Kits Market in 2024. The Northern and Central regions, particularly around Riyadh, house some of the country’s most prominent research institutions and universities. These institutions, including King Saud University, King Abdullah International Medical Research Center, and King Abdulaziz City for Science and Technology (KACST), are at the forefront of biotechnology research. These academic and research hubs generate a substantial demand for high-quality reagents and kits to support cutting-edge research in genomics, proteomics, molecular biology, and cell biology. The presence of these research institutions has positioned the region as a major consumer of biotechnology supplies.

Recent Development

• In November 2024, Bio-Techne Corporation, a global leader in life sciences offering cutting-edge tools and bioactive reagents for research and clinical diagnostics, announced a partnership with Leader Life Sciences. Through this agreement, Leader Life Sciences will serve as the distributor of Bio-Techne's product portfolio across the Gulf Cooperation Council (GCC) countries, including Bahrain, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.
• In November 2024, Bio-Techne Corporation announced the release of clinically significant spatial biology data. This data was produced using Bio-Techne’s Lunaphore-branded end-to-end spatial biology solution, which includes the full suite of instruments (COMET) and kits, providing high-value solutions for the translational research community. The COMET platform, a leading spatial biology system, integrates seamlessly into standard clinical research workflows, enabling the rapid development and validation of new panels with off-the-shelf, clinically IHC-validated antibodies.
• In January 2024, QIAGEN inaugurated its new regional headquarters in Riyadh, Saudi Arabia, further reinforcing the company’s commitment to the Middle East and enhancing its ability to serve clients in the region. Additionally, QIAGEN recently signed a Memorandum of Understanding (MoU) with the Saudi Arabian Ministry of Health, encompassing various public health and infection control initiatives in alignment with the Health Sector Transformation Program under Saudi Arabia’s Vision 2030.
• In February 2025, MGI Tech Co., Ltd. partnered with Oncoclínicas&Co, through OC Medicina de Precisão, which includes Genomics, Pathology, and Big Data laboratories, to enhance access to advanced genomic testing and bolster diagnostic capabilities in oncology across Brazil. Additionally, Oncoclínicas recently expanded its operations into Saudi Arabia through a joint venture with the Al Faisaliah Group, extending its mission to combat cancer to a new continent. This global expansion aims to deliver cutting-edge oncology care by integrating oncological hyperspecialization with innovative treatment strategies.

Key Market Players

• Dar Al Zahrawi Medical Co. Ltd
• Arabian Japanese Membrane Company, LLC
• Gulf Scientific for Laboratories
• QIAGEN N.V.
• Bio-Rad Saudi Arabia

Report Scope

In this report, the Saudi Arabia Biotechnology Reagents & Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Biotechnology Reagents & Kits Market, By Type:

o   Purification Kits

o   Amplification Kits

o   Detection Kits

o   Isolation Kits

o   Others

• Saudi Arabia Biotechnology Reagents & Kits Market, By Technology:

o   LAMP technology

o   PCR

o   Cell Culture

o   Sequencing

o   Chromatography

o   Electrophoresis

o   Flow Cytometry

o   Others

• Saudi Arabia Biotechnology Reagents & Kits Market, By Region:

o   Eastern

o   Western

o   Northern & Central

o   Southern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Biotechnology Reagents & Kits Market.

Available Customizations:

Saudi Arabia Biotechnology Reagents & Kits Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Biotechnology Reagents & Kits Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com